Hizal M, Bilgin B, Paksoy N, Atci MM, et al. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol 2022 Sep 1. pii: 10.1007/s00432-022-04252.
PMID: 36048274